LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 112 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.53 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $121,000 | +63.5% | 20,700 | -4.6% | 0.00% | 0.0% |
| Q4 2020 | $74,000 | +131.2% | 21,700 | -3.1% | 0.00% | – |
| Q3 2020 | $32,000 | -5.9% | 22,400 | +30.2% | 0.00% | – |
| Q2 2020 | $34,000 | -46.9% | 17,200 | -48.2% | 0.00% | -100.0% |
| Q1 2020 | $64,000 | -60.7% | 33,200 | -15.7% | 0.00% | -50.0% |
| Q4 2019 | $163,000 | -78.0% | 39,400 | -84.0% | 0.00% | -77.8% |
| Q3 2019 | $742,000 | -54.3% | 246,700 | -4.5% | 0.01% | -57.1% |
| Q2 2019 | $1,624,000 | +17.0% | 258,300 | +3.4% | 0.02% | +10.5% |
| Q1 2019 | $1,388,000 | +577.1% | 249,700 | +708.1% | 0.02% | +850.0% |
| Q4 2018 | $205,000 | +81.4% | 30,900 | +191.5% | 0.00% | +100.0% |
| Q3 2018 | $113,000 | +117.3% | 10,600 | +140.9% | 0.00% | 0.0% |
| Q2 2018 | $52,000 | +67.7% | 4,400 | +100.0% | 0.00% | – |
| Q1 2017 | $31,000 | +6.9% | 2,200 | +4.8% | 0.00% | – |
| Q4 2016 | $29,000 | +222.2% | 2,100 | +320.0% | 0.00% | – |
| Q3 2016 | $9,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 71,178,364 | $280,443,000 | 7.61% |
| BVF INC/IL | 14,360,000 | $56,578,000 | 2.05% |
| Integral Health Asset Management, LLC | 200,000 | $788,000 | 0.22% |
| Eversept Partners, LP | 797,694 | $3,142,914 | 0.20% |
| NEA Management Company, LLC | 2,382,286 | $9,386,000 | 0.19% |
| PINNACLE ASSOCIATES LTD | 2,127,662 | $8,383,000 | 0.14% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $141,000 | 0.06% |
| Virtus ETF Advisers LLC | 41,584 | $164,000 | 0.06% |
| Pegasus Asset Management, Inc. | 10,000 | $39,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 31,562 | $124,000 | 0.02% |